Month: May 2019

Late last week, Wall Street investment firm Jefferies initiated coverage on embattled marijuana stock Aphria (NYSE:APHA) with a buy rating and a price target of 15 Canadian dollars ($11.10), implying

Clear as mud. That’s pretty much the status of cannabidiol (CBD) products in the United States after the 2018 Farm Bill was signed into law in December. Although the bill

Investors and companies alike have been excited about the cannabis market. Once on the fringes of the financial world, cannabis companies are now gaining more traction, with mainstream companies jumping

The marijuana industry is shaping up to be a once-in-a-generation investment opportunity, although it’ll require the patience of long-term investors. On the surface, the legal weed industry looks to be

In case you haven’t been paying attention, the marijuana industry has been the buzz on Wall Street for more than two years, and for very good reason. With Canada lifting

The global cannabis industry is enjoying explosive growth. Hemp-derived cannabidiol (CBD) alone could become a $22 billion market by 2022, according to Brightfield Group, while the marijuana market could one

Momentum investing revolves around the idea of following a stock’s recent trend in either direction. In the ‘long’ context, investors will be essentially be “buying high, but hoping to sell